Patrick G. O'Connor

• Allen Hsiao
• Amy Justice
• Brent A Moore
• Christopher van Dyck
• David Fiellin
• Declan Barry
• Frederick Lewis Altice
• Gail D'Onofrio
• Gretchen Berland
• Heping Zhang
• Ismene Petrakis
• James Dziura
• Jeanette Tetrault
• Jody L. Sindelar
• John Krystal
• John P Moriarty
• Kathryn Hawk
• Leslie Curry
• Lisa Fucito
• Lloyd Friedman
• Lynn Tanoue
• Marc Rosen
• Marcella Nunez-Smith
• Marek Chawarski
• Margaret Pisani
• Mark Russi
• Mary Tinetti
• Ralitza Gueorguieva
• Richard Schottenfeld
• Robert Kerns
• Samuel Ball
• Sherry McKee
• Steve Martino
• Walter Kernan
• William Becker

Alcoholism; Education, Medical; Internal Medicine; Opioid-Related Disorders; Substance-Related Disorders; Physicians, Primary Care

• Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative studyJusten M, Edelman E, Chawarski M, Coupet E, Cowan E, Lyons M, Owens P, Martel S, Richardson L, Rothman R, Whiteside L, O'Connor P, Zahn E, D'Onofrio G, Fiellin D, Hawk K. Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative study. Journal Of Substance Use And Addiction Treatment 2023, 155: 209058. PMID: 37149149, DOI: 10.1016/j.josat.2023.209058.
• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine ProgramsSue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.
• Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use DisorderD’Onofrio G, Edelman E, Hawk K, Chawarski M, Pantalon M, Owens P, Martel S, Rothman R, Saheed M, Schwartz R, Cowan E, Richardson L, Salsitz E, Lyons M, Freiermuth C, Wilder C, Whiteside L, Tsui J, Klein J, Coupet E, O’Connor P, Matthews A, Murphy S, Huntley K, Fiellin D. Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder. JAMA Network Open 2023, 6: e235439. PMID: 37017967, PMCID: PMC10077107, DOI: 10.1001/jamanetworkopen.2023.5439.
• Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use DisorderLyons MS, Chawarski MC, Rothman R, Whiteside L, Cowan E, Richardson LD, Hawk K, Tsui JI, Schwartz RP, O’Connor P, D’Onofrio G, Fiellin DA, Edelman EJ. Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder. Journal Of Addiction Medicine 2022, 17: 210-214. PMID: 36170184, PMCID: PMC10023471, DOI: 10.1097/adm.0000000000001074.
• Models for Implementing Emergency Department–Initiated Buprenorphine With Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic CentersWhiteside LK, D'Onofrio G, Fiellin DA, Edelman EJ, Richardson L, O'Connor P, Rothman RE, Cowan E, Lyons MS, Fockele CE, Saheed M, Freiermuth C, Punches BE, Guo C, Martel S, Owens PH, Coupet E, Hawk KF. Models for Implementing Emergency Department–Initiated Buprenorphine With Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic Centers. Annals Of Emergency Medicine 2022, 80: 410-419. PMID: 35752520, PMCID: PMC9588652, DOI: 10.1016/j.annemergmed.2022.05.010.
• Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intakeOles W, Alexander M, Kumar N, Howell B, O’Connor P, Madden LM, Barry DT. Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake. BMC Psychiatry 2022, 22: 236. PMID: 35366844, PMCID: PMC8976510, DOI: 10.1186/s12888-022-03884-5.
• Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use DisorderHawk K, McCormack R, Edelman EJ, Coupet E, Toledo N, Gauthier P, Rotrosen J, Chawarski M, Martel S, Owens P, Pantalon MV, O’Connor P, Whiteside LK, Cowan E, Richardson LD, Lyons MS, Rothman R, Marsch L, Fiellin DA, D’Onofrio G. Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder. JAMA Network Open 2022, 5: e2144955. PMID: 35076700, PMCID: PMC8790663, DOI: 10.1001/jamanetworkopen.2021.44955.
• The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist PhysiciansCalcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor P. The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist Physicians. Substance Abuse 2022, 43: 143-151. PMID: 32267807, PMCID: PMC7541600, DOI: 10.1080/08897077.2020.1748169.
• Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIVMcGinnis KA, Tate JP, Bryant KJ, Justice AC, O’Connor P, Rodriguez-Barradas MC, Crystal S, Cutter CJ, Hansen NB, Maisto SA, Marconi VC, Williams EC, Cook RL, Gordon AJ, Gordon KS, Eyawo O, Edelman EJ, Fiellin DA. Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV. AIDS And Behavior 2021, 26: 786-794. PMID: 34542779, DOI: 10.1007/s10461-021-03438-y.
• Association of Socioeconomic Status With Alpha Omega Alpha Honor Society Membership Among Medical StudentsNguyen M, Mason HRC, O’Connor P, Nunez-Smith M, McDade WA, Latimore D, Boatright D. Association of Socioeconomic Status With Alpha Omega Alpha Honor Society Membership Among Medical Students. JAMA Network Open 2021, 4: e2110730. PMID: 34076702, PMCID: PMC8173376, DOI: 10.1001/jamanetworkopen.2021.10730.
• The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic reviewKumar N, Oles W, Howell BA, Janmohamed K, Lee ST, Funaro MC, O'Connor PG, Alexander M. The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review. Journal Of Substance Use And Addiction Treatment 2021, 127: 108367. PMID: 34134871, PMCID: PMC9022048, DOI: 10.1016/j.jsat.2021.108367.
• The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED InnovationD'Onofrio G, Hawk KF, Herring AA, Perrone J, Cowan E, McCormack RP, Dziura J, Taylor RA, Coupet E, Edelman EJ, Pantalon MV, Owens PH, Martel SH, O'Connor PG, Van Veldhuisen P, DeVogel N, Huntley K, Murphy SM, Lofwall MR, Walsh SL, Fiellin DA. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation. Contemporary Clinical Trials 2021, 104: 106359. PMID: 33737199, PMCID: PMC9153252, DOI: 10.1016/j.cct.2021.106359.
• A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needsHawk K, Grau LE, Fiellin DA, Chawarski M, O’Connor P, Cirillo N, Breen C, D’Onofrio G. A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs. Academic Emergency Medicine 2021, 28: 542-552. PMID: 33346926, PMCID: PMC8281441, DOI: 10.1111/acem.14197.
• Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatmentCoupet E, D’Onofrio G, Chawarski M, Edelman E, O’Connor P, Owens P, Martel S, Fiellin DA, Cowan E, Richardson L, Huntley K, Whiteside LK, Lyons MS, Rothman RE, Pantalon M, Hawk K. Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment. Drug And Alcohol Dependence 2020, 219: 108428. PMID: 33307301, PMCID: PMC8110210, DOI: 10.1016/j.drugalcdep.2020.108428.
• Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical TrainingMuvvala SB, Schwartz ML, Petrakis I, O'Connor P, Tetrault JM. Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical Training. Substance Abuse 2020, 41: 475-479. PMID: 31951809, DOI: 10.1080/08897077.2019.1709606.
• Validating Self‐Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIVEyawo O, Deng Y, Dziura J, Justice AC, McGinnis K, Tate JP, Rodriguez‐Barradas M, Hansen NB, Maisto SA, Marconi VC, O’Connor P, Bryant K, Fiellin DA, Edelman EJ. Validating Self‐Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV. Alcohol Clinical And Experimental Research 2020, 44: 2053-2063. PMID: 33460225, PMCID: PMC8856627, DOI: 10.1111/acer.14435.
• Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician SpecialistsNunes EV, Kunz K, Galanter M, O'Connor PG. Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists. American Journal On Addictions 2020, 29: 390-400. PMID: 32902056, DOI: 10.1111/ajad.13068.
• Racial Privilege and Medical Student Awards: Addressing Racial Disparities in Alpha Omega Alpha Honor Society MembershipBoatright D, O’Connor P, E. Miller J. Racial Privilege and Medical Student Awards: Addressing Racial Disparities in Alpha Omega Alpha Honor Society Membership. Journal Of General Internal Medicine 2020, 35: 3348-3351. PMID: 32869203, PMCID: PMC7661606, DOI: 10.1007/s11606-020-06161-x.
• Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use DisorderChawarski MC, Hawk K, Edelman EJ, O'Connor P, Owens P, Martel S, Coupet E, Whiteside L, Tsui JI, Rothman R, Cowan E, Richardson L, Lyons MS, Fiellin DA, D'Onofrio G. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder. Annals Of Emergency Medicine 2020, 76: 782-787. PMID: 32782084, PMCID: PMC8048036, DOI: 10.1016/j.annemergmed.2020.06.046.
• Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trialEdelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O’Connor P, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial. Addiction Science & Clinical Practice 2020, 15: 28. PMID: 32727618, PMCID: PMC7388231, DOI: 10.1186/s13722-020-00200-y.
• Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholdersJoudrey PJ, Oldfield BJ, Yonkers KA, O'Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders. Drug And Alcohol Dependence 2020, 213: 108090. PMID: 32559667, PMCID: PMC7375447, DOI: 10.1016/j.drugalcdep.2020.108090.
• Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT.Tetrault JM, Holt SR, Cavallo DA, O'Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT. Journal Of Addiction Medicine 2020, 14: e303-e309. PMID: 32371660, DOI: 10.1097/adm.0000000000000663.
• Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated BuprenorphineHawk KF, D’Onofrio G, Chawarski MC, O’Connor P, Cowan E, Lyons MS, Richardson L, Rothman RE, Whiteside LK, Owens PH, Martel SH, Coupet E, Pantalon M, Curry L, Fiellin DA, Edelman EJ. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine. JAMA Network Open 2020, 3: e204561. PMID: 32391893, PMCID: PMC7215257, DOI: 10.1001/jamanetworkopen.2020.4561.
• Alcohol use disorder.O’Connor PG. Alcohol use disorder. In Goldman-Cecil Medicine, 26th edition, 2020, Chapter 30, pages 143-150.
• Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trialEdelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial. Journal Of Substance Use And Addiction Treatment 2019, 106: 97-106. PMID: 31540617, PMCID: PMC7244228, DOI: 10.1016/j.jsat.2019.08.007.
• Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialEdelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. The Lancet HIV 2019, 6: e509-e517. PMID: 31109915, PMCID: PMC7161741, DOI: 10.1016/s2352-3018(19)30076-1.
• Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)D’Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM, Huntley K, O’Connor P, Fiellin DA. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implementation Science 2019, 14: 48. PMID: 31064390, PMCID: PMC6505286, DOI: 10.1186/s13012-019-0891-5.
• A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical resultsBernstein SL, Weiss J, DeWitt M, Tetrault JM, Hsiao AL, Dziura J, Sussman S, Miller T, Carpenter K, O’Connor P, Toll B. A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results. Implementation Science 2019, 14: 8. PMID: 30670043, PMCID: PMC6343239, DOI: 10.1186/s13012-019-0856-8.
• The Opioid Crisis: Understanding the Complexities, Acknowledging the Challenges, and Exploring Possible Solutions.O'Connor, PG, et al. AHLA White Paper, The Opioid Crisis: Understanding the Complexities, Acknowledging the Challenges, and Exploring Possible Solutions. American Health Law Association. Feb 20, 2019.
• 5EMF Developing an Emergency Department-Based Intervention to Prevent Opioid Overdose: Listening to Patient VoicesHawk K, Grau L, Fiellin D, Pantalon M, Chawarski M, O'Connor P, D'Onofrio G. 5EMF Developing an Emergency Department-Based Intervention to Prevent Opioid Overdose: Listening to Patient Voices. Annals Of Emergency Medicine 2018, 72: s155. DOI: 10.1016/j.annemergmed.2018.08.402.
• Increasing Resident Participation in Research: Capitalizing on Local Resources to Maximize SuccessWindish DM, Huot SJ, O’Connor P, Moriarty JP. Increasing Resident Participation in Research: Capitalizing on Local Resources to Maximize Success. Journal Of General Internal Medicine 2018, 33: 1836-1838. PMID: 29992425, PMCID: PMC6206342, DOI: 10.1007/s11606-018-4553-0.
• The Internist’s Challenge: Addressing Our Patients’ Unhealthy Substance UseSamet JH, O'Connor PG, Stein MD. The Internist’s Challenge: Addressing Our Patients’ Unhealthy Substance Use. Medical Clinics Of North America 2018, 102: xvii-xviii. PMID: 29933831, DOI: 10.1016/j.mcna.2018.04.001.
• Unhealthy alcohol use, including alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course assessment, and diagnosis.Tetrault JM, O’Connor PG. Unhealthy alcohol use, including alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course assessment, and diagnosis. UpToDate 2015. Updated Sept 13, 2018.
• Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use DisorderHawk K, D'Onofrio G, Fiellin DA, Chawarski MC, O'Connor PG, Owens PH, Pantalon MV, Bernstein SL. Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use Disorder. Academic Emergency Medicine 2017, 25: 508-516. PMID: 29165853, PMCID: PMC5963969, DOI: 10.1111/acem.13352.
• Proceedings of the 14th annual conference of INEBRIAHolloway A, Ferguson J, Landale S, Cariola L, Newbury-Birch D, Flynn A, Knight J, Sherritt L, Harris S, O’Donnell A, Kaner E, Hanratty B, Loree A, Yonkers K, Ondersma S, Gilstead-Hayden K, Martino S, Adam A, Schwartz R, Wu L, Subramaniam G, Sharma G, McNeely J, Berman A, Kolaas K, Petersén E, Bendtsen P, Hedman E, Linderoth C, Müssener U, Sinadinovic K, Spak F, Gremyr I, Thurang A, Mitchell A, Finnell D, Savage C, Mahmoud K, Riordan B, Conner T, Flett J, Scarf D, McRee B, Vendetti J, Gallucci K, Robaina K, Clark B, Jones J, Reed K, Hodapp R, Douglas I, Burnham E, Aagaard L, Cook P, Harris B, Yu J, Wolff M, Rogers M, Barbosa C, Wedehase B, Dunlap L, Mitchell S, Dusek K, Gryczynski J, Kirk A, Oros M, Hosler C, O’Grady K, Brown B, Angus C, Sherborne S, Gillespie D, Meier P, Brennan A, de Vargas D, Soares J, Castelblanco D, Doran K, Wittman I, Shelley D, Rotrosen J, Gelberg L, Edelman E, Maisto S, Hansen N, Cutter C, Deng Y, Dziura J, Fiellin L, O’Connor P, Bedimo R, Gibert C, Marconi V, Rimland D, Rodriguez-Barradas M, Simberkoff M, Justice A, Bryant K, Fiellin D, Giles E, Coulton S, Deluca P, Drummond C, Howel D, McColl E, McGovern R, Scott S, Stamp E, Sumnall H, Vale L, Alabani V, Atkinson A, Boniface S, Frankham J, Gilvarry E, Hendrie N, Howe N, McGeechan G, Ramsey A, Stanley G, Clephane J, Gardiner D, Holmes J, Martin N, Shevills C, Soutar M, Chi F, Weisner C, Ross T, Mertens J, Sterling S, Shorter G, Heather N, Bray J, Cohen H, McPherson T, Adam C, López-Pelayo H, Gual A, Segura-Garcia L, Colom J, Ornelas I, Doyle S, Donovan D, Duran B, Torres V, Gaume J, Grazioli V, Fortini C, Paroz S, Bertholet N, Daeppen J, Satterfield J, Gregorich S, Alvarado N, Muñoz R, Kulieva G, Vijayaraghavan M, Adam A, Cunningham J, Díaz E, Palacio-Vieira J, Godinho A, Kushir V, O’Brien K, Aguinaldo L, Sellers C, Spirito A, Chang G, Blake-Lamb T, LaFave L, Thies K, Pepin A, Sprangers K, Bradley M, Jorgensen S, Catano N, Murray A, Schachter D, Andersen R, Rey G, Vahidi M, Rico M, Baumeister S, Johansson M, Sinadinovic C, Hermansson U, Andreasson S, O’Grady M, Kapoor S, Akkari C, Bernal C, Pappacena K, Morley J, Auerbach M, Neighbors C, Kwon N, Conigliaro J, Morgenstern J, Magill M, Apodaca T, Borsari B, Hoadley A, Scott Tonigan J, Moyers T, Fitzgerald N, Schölin L, Barticevic N, Zuzulich S, Poblete F, Norambuena P, Sacco P, Ting L, Beaulieu M, Wallace P, Andrews M, Daley K, Shenker D, Gallagher L, Watson R, Weaver T, Bruguera P, Oliveras C, Gavotti C, Barrio P, Braddick F, Miquel L, Suárez M, Bruguera C, Brown R, Capell J, Paul Moberg D, Maslowsky J, Saunders L, McCormack R, Scheidell J, Gonzalez M, Bauroth S, Liu W, Lindsay D, Lincoln P, Hagle H, Wallhed Finn S, Hammarberg A, Andréasson S, King S, Vargo R, Kameg B, Acquavita S, Van Loon R, Smith R, Brehm B, Diers T, Kim K, Barker A, Jones A, Skinner A, Hinman A, Svikis D, Thacker C, Resnicow K, Beatty J, Janisse J, Puder K, Bakshi A, Milward J, Kimergard A, Garnett C, Crane D, Brown J, West R, Michie S, Rosendahl I, Andersson C, Gajecki M, Blankers M, Donoghue K, Lynch E, Maconochie I, Phillips C, Pockett R, Phillips T, Patton R, Russell I, Strang J, Stewart M, Quinn A, Brolin M, Evans B, Horgan C, Liu J, McCree F, Kanovsky D, Oberlander T, Zhang H, Hamlin B, Saunders R, Barton M, Scholle S, Santora P, Bhatt C, Ahmed K, Hodgkin D, Gao W, Merrick E, Drebing C, Larson M, Sharma M, Petry N, Saitz R, Weisner C, Young-Wolff K, Lu W, Blosnich J, Lehavot K, Glass J, Williams E, Bensley K, Chan G, Dombrowski J, Fortney J, Rubinsky A, Lapham G, Forray A, Olmstead T, Gilstad-Hayden K, Kershaw T, Dillon P, Weaver M, Grekin E, Ellis J, McGoron L, McGoron L. Proceedings of the 14th annual conference of INEBRIA. Addiction Science & Clinical Practice 2017, 12: 25. PMCID: PMC5606215, DOI: 10.1186/s13722-017-0087-8.
• Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practiceDonroe JH, Holt SR, O’Connor P, Sukumar N, Tetrault JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug And Alcohol Dependence 2017, 180: 46-51. PMID: 28866369, DOI: 10.1016/j.drugalcdep.2017.07.040.
• Cost‐effectiveness of emergency department‐initiated treatment for opioid dependenceBusch SH, Fiellin DA, Chawarski MC, Owens PH, Pantalon MV, Hawk K, Bernstein SL, O'Connor PG, D'Onofrio G. Cost‐effectiveness of emergency department‐initiated treatment for opioid dependence. Addiction 2017, 112: 2002-2010. PMID: 28815789, PMCID: PMC5657503, DOI: 10.1111/add.13900.
• Corrigendum to “The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients” [Contemp. Clin. Trials 52 (2017) 80–90]Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, O'Connor PG, Bedimo R, Gibert C, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Justice AC, Bryant KJ, Fiellin DA. Corrigendum to “The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients” [Contemp. Clin. Trials 52 (2017) 80–90]. Contemporary Clinical Trials 2017, 60: 125. PMID: 28712767, DOI: 10.1016/j.cct.2017.06.016.
• An Interventionist Adherence Scale for a Specialized Brief Negotiation Interview Focused on Treatment Engagement for Opioid use DisordersPantalon MV, Dziura J, Li FY, Owens PH, O'Connor PG, D'Onofrio G. An Interventionist Adherence Scale for a Specialized Brief Negotiation Interview Focused on Treatment Engagement for Opioid use Disorders. Substance Abuse 2017, 38: 191-199. PMID: 28398192, PMCID: PMC7222694, DOI: 10.1080/08897077.2017.1294548.
• Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After InterventionD’Onofrio G, Chawarski MC, O’Connor P, Pantalon MV, Busch SH, Owens PH, Hawk K, Bernstein SL, Fiellin DA. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention. Journal Of General Internal Medicine 2017, 32: 660-666. PMID: 28194688, PMCID: PMC5442013, DOI: 10.1007/s11606-017-3993-2.
• The research in addiction medicine scholars program-developing researchers in addiction fellowshipsO’Connor P, Tsui J, Gobel D, Brett B, Bridden C, Samet J. The research in addiction medicine scholars program-developing researchers in addiction fellowships. Drug And Alcohol Dependence 2017, 171: e154. DOI: 10.1016/j.drugalcdep.2016.08.425.
• Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patientsEdelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, O'Connor PG, Bedimo R, Gibert C, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Justice AC, Bryant KJ, Fiellin DA. Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients. Contemporary Clinical Trials 2016, 52: 80-90. PMID: 27876616, PMCID: PMC5253227, DOI: 10.1016/j.cct.2016.11.008.
• Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine TreatmentMoore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfeld RS. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal Of Substance Use And Addiction Treatment 2016, 71: 54-57. PMID: 27776678, PMCID: PMC5119533, DOI: 10.1016/j.jsat.2016.08.016.
• Implementation of integrated stepped care for unhealthy alcohol use in HIV clinicsEdelman EJ, Hansen NB, Cutter CJ, Danton C, Fiellin LE, O’Connor P, Williams EC, Maisto SA, Bryant KJ, Fiellin DA. Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics. Addiction Science & Clinical Practice 2016, 11: 1. PMID: 26763048, PMCID: PMC4711105, DOI: 10.1186/s13722-015-0048-z.
• Integrated Curriculum and Core Competencies on Prevention of Risky Substance Use and Treatment of Addiction.O’Connor PG, et al. Medicine Responds to Addiction Symposium II Proceedings, Executive Office of the President of the United States, Office of National Drug Control Policy, The American Board of Addiction Medicine Foundation. "Integrated Curriculum and Core Competencies on Prevention of Risky Substance Use and Treatment of Addiction.” The White House, Washington, DC. October 2016.
• Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health.O’Connor, PG et al. U.S. Department of Health and Human Services (HHS), Office of the Surgeon General, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: HHS, November 2016.
• Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependenceBusch S, Hawk K, Fiellin D, O’Connor P, Chawarski M, Owens P, Pantalon M, Bernstein S, D’Onofrio G. Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependence. Drug And Alcohol Dependence 2015, 156: e32. DOI: 10.1016/j.drugalcdep.2015.07.1005.
• A randomized clinical trial of emergency department initiated treatment for opioid dependence: Two and six month outcomesD’Onofrio G, O’Connor P, Pantalon M, Chawarski M, Busch S, Owens P, Bernstein S, Fiellin D. A randomized clinical trial of emergency department initiated treatment for opioid dependence: Two and six month outcomes. Drug And Alcohol Dependence 2015, 156: e53. DOI: 10.1016/j.drugalcdep.2015.07.1062.
• Opioid Dependence Treatment in the Emergency Department—ReplyFiellin DA, O’Connor P, D’Onofrio G. Opioid Dependence Treatment in the Emergency Department—Reply. JAMA 2015, 314: 835-835. PMID: 26305657, DOI: 10.1001/jama.2015.8527.
• An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosateGueorguieva R, Wu R, Tsai WM, O’Connor P, Fucito L, Zhang H, O’Malley S. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate. European Neuropsychopharmacology 2015, 25: 1586-1599. PMID: 26141511, PMCID: PMC4600651, DOI: 10.1016/j.euroneuro.2015.06.006.
• Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical TrialD’Onofrio G, O’Connor P, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA 2015, 313: 1636-1644. PMID: 25919527, PMCID: PMC4527523, DOI: 10.1001/jama.2015.3474.
• Overdose Education and Naloxone Rescue Kits for Family Members of Individuals who Use Opioids: Characteristics, Motivations, and Naloxone UseBagley SM, Peterson J, Cheng DM, Jose C, Quinn E, O'Connor P, Walley AY. Overdose Education and Naloxone Rescue Kits for Family Members of Individuals who Use Opioids: Characteristics, Motivations, and Naloxone Use. Substance Abuse 2015, 36: 149-154. PMID: 25564892, PMCID: PMC4809347, DOI: 10.1080/08897077.2014.989352.
• Addressing Bias in Observational Studies of Alcohol Withdrawal Syndrome: A Call to the FieldFiellin DA, Samet JH, O'Connor PG. Addressing Bias in Observational Studies of Alcohol Withdrawal Syndrome: A Call to the Field. Alcohol Clinical And Experimental Research 2015, 39: 390-390. PMID: 25665029, DOI: 10.1111/acer.12634.
• Overdose education and naloxone rescue kits for family members of opioid users: Characteristics, motivations and naloxone useBagley S, Peterson J, Cheng D, Jose C, O’Connor P, Walley A. Overdose education and naloxone rescue kits for family members of opioid users: Characteristics, motivations and naloxone use. Drug And Alcohol Dependence 2015, 146: e213. DOI: 10.1016/j.drugalcdep.2014.09.048.
• Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependenceFiellin D, Cutter C, Moore B, Barry D, O’Connor P, Schottenfeld R. Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependence. Drug And Alcohol Dependence 2015, 146: e277. DOI: 10.1016/j.drugalcdep.2014.09.220.
• Cognitive behavioral therapy improves treatment outcome for prescription opioid users in primary care based buprenorphine/naloxone treatmentCutter C, Moore B, Barry D, Fiellin L, Schottenfeld R, Fiellin D, O’Connor P. Cognitive behavioral therapy improves treatment outcome for prescription opioid users in primary care based buprenorphine/naloxone treatment. Drug And Alcohol Dependence 2015, 146: e255. DOI: 10.1016/j.drugalcdep.2014.09.160.
• The Fix Addiction and Recovery, Straight Up by John Lavitt.O’Connor, PG. The Fix Addiction and Recovery, Straight Up by John Lavitt, December 4, 2015. Ensuring High Quality Addiction Care for All: The Fix Q&A with the President of the American Board of Addiction Medicine.
• Input from the Field: Panel of Medical Leaders and Champions.O’Connor PG, et al. Medicine Responds to Addiction Proceedings, Executive Office of the President of the United States, Office of National Drug Control Policy, The American Board of Addiction Medicine Foundation. "Imput from the Field: Panel of Medical Leaders and Champions.” The White House, Washington, DC. September 2015.
• Alcohol use disorder.O’Connor PG. Alcohol use disorder. In Goldman-Cecil Medicine, 25th Edition, 2015:149-156.
• Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical TrialFiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor P. Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial. JAMA Internal Medicine 2014, 174: 1947-1954. PMID: 25330017, PMCID: PMC6167926, DOI: 10.1001/jamainternmed.2014.5302.
• Addiction Medicine: The Birth of a New DisciplineO’Connor P, Sokol RJ, D’Onofrio G. Addiction Medicine: The Birth of a New Discipline. JAMA Internal Medicine 2014, 174: 1717-1718. PMID: 25201642, DOI: 10.1001/jamainternmed.2014.4211.
• Predictors of Abstinence from Heavy Drinking During Treatment in COMBINE and External Validation in PREDICTGueorguieva R, Wu R, O'Connor PG, Weisner C, Fucito LM, Hoffmann S, Mann K, O'Malley SS. Predictors of Abstinence from Heavy Drinking During Treatment in COMBINE and External Validation in PREDICT. Alcohol Clinical And Experimental Research 2014, 38: 2647-2656. PMID: 25346505, PMCID: PMC4397985, DOI: 10.1111/acer.12541.
• The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patientsEdelman EJ, Chantarat T, Caffrey S, Chaudhry A, O’Connor P, Weiss L, Fiellin DA, Fiellin LE. The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. Drug And Alcohol Dependence 2014, 139: 79-85. PMID: 24726429, PMCID: PMC4029496, DOI: 10.1016/j.drugalcdep.2014.03.006.
• Managing Substance Dependence as a Chronic Disease: Is the Glass Half Full or Half Empty?O’Connor P. Managing Substance Dependence as a Chronic Disease: Is the Glass Half Full or Half Empty? JAMA 2013, 310: 1132-1134. PMID: 24045739, DOI: 10.1001/jama.2013.277610.
• A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based BuprenorphineFiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, Schottenfeld RS. A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine. The American Journal Of Medicine 2013, 126: 74.e11-74.e17. PMID: 23260506, PMCID: PMC3621718, DOI: 10.1016/j.amjmed.2012.07.005.
• Development of a scale to measure practitioner adherence to a brief intervention in the emergency departmentPantalon MV, Martino S, Dziura J, Li FY, Owens PH, Fiellin DA, O'Connor PG, D'Onofrio G. Development of a scale to measure practitioner adherence to a brief intervention in the emergency department. Journal Of Substance Use And Addiction Treatment 2012, 43: 382-388. PMID: 23021098, PMCID: PMC3661016, DOI: 10.1016/j.jsat.2012.08.011.
• Counseling and Directly Observed Medication for Primary Care Buprenorphine MaintenanceMoore BA, Barry DT, Sullivan LE, O'Connor PG, Cutter CJ, Schottenfeld RS, Fiellin DA. Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance. Journal Of Addiction Medicine 2012, 6: 205-211. PMID: 22614936, PMCID: PMC3419276, DOI: 10.1097/adm.0b013e3182596492.
• Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patientsTetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal Of Substance Use And Addiction Treatment 2012, 43: 433-439. PMID: 22938914, DOI: 10.1016/j.jsat.2012.07.011.
• Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency CurriculumRyan SA, Martel S, Pantalon M, Martino S, Tetrault J, Thung SF, Bernstein SL, Auinger P, Green ML, Fiellin DA, O'Connor P, D'Onofrio G. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency Curriculum. Substance Abuse 2012, 33: 251-260. PMID: 22738002, DOI: 10.1080/08897077.2011.640182.
• Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT)Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor P, Fiellin DA, D'Onofrio G. Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Substance Abuse 2012, 33: 168-181. PMID: 22489589, DOI: 10.1080/08897077.2011.640220.
• A Brief Intervention Reduces Hazardous and Harmful Drinking in Emergency Department PatientsD'Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O'Connor PG. A Brief Intervention Reduces Hazardous and Harmful Drinking in Emergency Department Patients. Annals Of Emergency Medicine 2012, 60: 181-192. PMID: 22459448, PMCID: PMC3811141, DOI: 10.1016/j.annemergmed.2012.02.006.
• Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical PracticeSigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice. The American Journal Of Drug And Alcohol Abuse 2012, 38: 187-199. PMID: 22404717, PMCID: PMC4331107, DOI: 10.3109/00952990.2011.653426.
• Alcohol Abuse and Dependence.O’Connor PG. Alcohol Abuse and Dependence. In Goldman’s Cecil Medicine, 24th Edition, 2012.
• Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al”Vergara-Rodriguez P, Tozzi M, Botsko M, Nandi V, Altice F, Egan J, O'Connor P, Sullivan L, Fiellin D. Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al”. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 58: e112-e113. DOI: 10.1097/qai.0b013e318232e955.
• Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent PatientsVergara-Rodriguez P, Tozzi MJ, Botsko M, Nandi V, Altice F, Egan JE, O'Connor PG, Sullivan LE, Fiellin DA. Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: s62-s67. PMID: 21317596, DOI: 10.1097/qai.0b013e31820a820f.
• Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/NaloxoneFiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG. Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: s33-s38. PMID: 21317592, PMCID: PMC3863630, DOI: 10.1097/qai.0b013e3182097537.
• The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/NaloxoneSullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA. The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: s54-s61. PMID: 21317595, PMCID: PMC3065971, DOI: 10.1097/qai.0b013e3182097576.
• Integrating addiction medicine into graduate medical education in primary care: the time has come.O'Connor PG, Nyquist JG, McLellan AT. Integrating addiction medicine into graduate medical education in primary care: the time has come. Annals Of Internal Medicine 2011, 154: 56-9. PMID: 21200039, DOI: 10.7326/0003-4819-154-1-201101040-00008.
• Drug Use and Dependence.O'Connor PG, "Drug Use and Dependence," In The Merck Manual of Diagnosis and Therapy, 19th Edition, 2011.
• Medications for unhealthy alcohol use: across the spectrum.O'Malley SS, O'Connor PG. Medications for unhealthy alcohol use: across the spectrum. Alcohol Research 2011, 33: 300-12. PMID: 23580015, PMCID: PMC3860540.
• The Safety of Opioid Analgesics in the Elderly: New Data Raise New Concerns: Comment on “The Comparative Safety of Opioids for Nonmalignant Pain in Older Adults”Becker WC, O'Connor PG. The Safety of Opioid Analgesics in the Elderly: New Data Raise New Concerns: Comment on “The Comparative Safety of Opioids for Nonmalignant Pain in Older Adults”. JAMA Internal Medicine 2010, 170: 1986-1988. PMID: 21149755, DOI: 10.1001/archinternmed.2010.443.
• Advances in the Treatment of Opioid Dependence: Continued Progress and Ongoing ChallengesO’Connor P. Advances in the Treatment of Opioid Dependence: Continued Progress and Ongoing Challenges. JAMA 2010, 304: 1612-1614. PMID: 20940391, DOI: 10.1001/jama.2010.1496.
• Health risk behaviors and injured patients: an exploratory studyDegutis C, Busch S, Pantalon M, Fiellin D, O'Connor P, D'Onofrio G. Health risk behaviors and injured patients: an exploratory study. Injury Prevention 2010, 16: a133. DOI: 10.1136/ip.2010.029215.477.
• Opioids, Chronic Pain, and Addiction in Primary CareBarry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Opioids, Chronic Pain, and Addiction in Primary Care. Journal Of Pain 2010, 11: 1442-1450. PMID: 20627817, PMCID: PMC2955997, DOI: 10.1016/j.jpain.2010.04.002.
• The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid DependenceSullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, Fiellin DA. The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence. American Journal On Addictions 2009, 19: 53-58. PMID: 20132122, PMCID: PMC3107713, DOI: 10.1111/j.1521-0391.2009.00003.x.
• Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer PainChou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, Panel A. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. Journal Of Pain 2009, 10: 113-130.e22. PMID: 19187889, PMCID: PMC4043401, DOI: 10.1016/j.jpain.2008.10.008.
• Alcohol Abuse and Dependency.O’Connor PG. Section 13 / Chapter III Alcohol Abuse and Dependency. In ACP Medicine Textbook. American College of Physicians, 2009.
• Management of Opioid Intoxication and Withdrawal.Tetrault JM, O’Connor PG. Management of Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, 4th Edition, Lippincott Williams & Wilkins, Inc., Philadelphia, PA, 2009, pp. 589-603.
• Drug Use and Abuse.O'Connor PG. Drug Use and Abuse. In The Merck of Medical Information Home Edition, Merck & Co., Inc., Whitehouse Station, NJ and printed in The Merck Manual Home Health Handbook, Merck Research Laboratories, Division of Merck & Co., Inc., Whitehouse Station, NJ, 2009.
• Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyBarry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor P, Schottenfeld RS, Fiellin DA. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal Of General Internal Medicine 2008, 24: 218-225. PMID: 19089500, PMCID: PMC2628993, DOI: 10.1007/s11606-008-0881-9.
• Substance Abuse and Withdrawal in the Critical Care SettingTetrault JM, O'Connor PG. Substance Abuse and Withdrawal in the Critical Care Setting. Critical Care Clinics 2008, 24: 767-788. PMID: 18929942, DOI: 10.1016/j.ccc.2008.05.005.
• Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patientsJones ES, Moore BA, Sindelar JL, O’Connor P, Schottenfeld RS, Fiellin DA. Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug And Alcohol Dependence 2008, 99: 132-140. PMID: 18804923, PMCID: PMC2646001, DOI: 10.1016/j.drugalcdep.2008.07.013.
• Brief Intervention for Hazardous and Harmful Drinkers in the Emergency DepartmentD'Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, Busch SH, Chawarski MC, Owens PH, O'Connor PG. Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department. Annals Of Emergency Medicine 2008, 51: 742-750.e2. PMID: 18436340, PMCID: PMC2819119, DOI: 10.1016/j.annemergmed.2007.11.028.
• Disagreement Between Students and Preceptors Regarding the Value of Teaching Behaviors for Ambulatory Care SettingsKernan WN, Hershman W, Alper EJ, Lee MY, Viscoli CM, Perry JR, O'Connor PG. Disagreement Between Students and Preceptors Regarding the Value of Teaching Behaviors for Ambulatory Care Settings. Teaching And Learning In Medicine 2008, 20: 143-150. PMID: 18444201, DOI: 10.1080/10401330801991667.
• Long‐Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 YearsFiellin DA, Moore BA, Sullivan LE, Becker WC, Pantalon MV, Chawarski MC, Barry DT, O'Connor PG, Schottenfeld RS. Long‐Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 Years. American Journal On Addictions 2008, 17: 116-120. PMID: 18393054, DOI: 10.1080/10550490701860971.
• Medical and Postgraduate Education in Substance Abuse.O’Connor PG. Medical and Postgraduate Education in Substance Abuse. 2008 Update on Addiction Medicine/Psychiatry in the State of Connecticut 2008, 72(4): 219-221.
• Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsSullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Journal Of Substance Use And Addiction Treatment 2007, 35: 87-92. PMID: 17933486, PMCID: PMC2587397, DOI: 10.1016/j.jsat.2007.08.004.
• Improving substance abuse treatment for women: a golden opportunity.O'Connor PG. Improving substance abuse treatment for women: a golden opportunity. Substance Abuse : Official Publication Of The Association For Medical Education And Research In Substance Abuse 2007, 28: 1-2. PMID: 19266707.
• Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependenceChawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. Journal Of Substance Use And Addiction Treatment 2007, 33: 411-415. PMID: 17512157, PMCID: PMC3632440, DOI: 10.1016/j.jsat.2007.03.004.
• Assessing Patients’ Readiness to ChangeO'Connor P. Assessing Patients’ Readiness to Change. Substance Abuse 2007, 28: 1-2. DOI: 10.1300/j465v28n01_01.
• Smoking Status as a Clinical Indicator for Alcohol Misuse in US AdultsMcKee SA, Falba T, O’Malley S, Sindelar J, O’Connor P. Smoking Status as a Clinical Indicator for Alcohol Misuse in US Adults. JAMA Internal Medicine 2007, 167: 716-721. PMID: 17420431, PMCID: PMC2869385, DOI: 10.1001/archinte.167.7.716.
• Assessing patients' readiness to change: inching toward an elusive goal.O'Connor PG. Assessing patients' readiness to change: inching toward an elusive goal. Substance Abuse : Official Publication Of The Association For Medical Education And Research In Substance Abuse 2007, 28: 1-2. PMID: 19263557, DOI: 10.1300/J465v28n02_01.
• Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent PatientsMoore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O’Connor P, Schottenfeld RS. Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients. Journal Of General Internal Medicine 2007, 22: 527-530. PMID: 17372805, PMCID: PMC1829433, DOI: 10.1007/s11606-007-0129-0.
• Brief interventions for problem drinking: another piece of the puzzle.O'Connor PG. Brief interventions for problem drinking: another piece of the puzzle. Annals Of Internal Medicine 2007, 146: 223-5. PMID: 17283352, DOI: 10.7326/0003-4819-146-3-200702060-00012.
• Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone TreatmentBarry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O’Connor P, Schottenfeld RS, Fiellin DA. Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment. Journal Of General Internal Medicine 2007, 22: 242-245. PMID: 17356993, PMCID: PMC1824745, DOI: 10.1007/s11606-006-0050-y.
• Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Annals Of Internal Medicine 2007, 146: 116-27. PMID: 17227935, DOI: 10.7326/0003-4819-146-2-200701160-00006.
• Diagnosis and pharmacologic management of opioid dependency.Jones ES and O’Connor PG. Diagnosis and pharmacologic management of opioid dependency. Hospital Physician 2007, 43(10)15-24, 39.
• Alcohol Abuse and Dependence.O’Connor PG. Alcohol Abuse and Dependence. In Goldman Cecil Medicine, 23rd Edition, W.B. Saunders Company, A Division of Harcourt Health Science, 2007.
• The Science of Addiction: From Neurobiology to Treatment, by Carlton K. Erickson (Book Review).O’Connor PG. The Science of Addiction: From Neurobiology to Treatment, by Carlton K. Erickson (Book Review). New England Journal of Medicine 2007, 357(16)1671-72.
• A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical CareSullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.
• A Randomized Trial of Primary Intensive Care to Reduce Hospital Admissions in Patients with High Utilization of Inpatient ServicesSledge WH, Brown KE, Levine JM, Fiellin DA, Chawarski M, White WD, O'Connor PG. A Randomized Trial of Primary Intensive Care to Reduce Hospital Admissions in Patients with High Utilization of Inpatient Services. Population Health Management 2006, 9: 328-338. PMID: 17115880, DOI: 10.1089/dis.2006.9.328.
• Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceFiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS. Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence. New England Journal Of Medicine 2006, 355: 365-374. PMID: 16870915, DOI: 10.1056/nejmoa055255.
• High Rate of Negative Results of Tuberculin and QuantiFERON Tests Among Individuals With a History of Positive Skin Test ResultsFriedman LN, Nash ER, Bryant J, Henry S, Shi J, D'Amato J, Khaled GH, Russi MB, O'Connor PG, Edberg SC, Pisani MA, Cain HC, Tanoue L, Weissman DN. High Rate of Negative Results of Tuberculin and QuantiFERON Tests Among Individuals With a History of Positive Skin Test Results. Infection Control And Hospital Epidemiology 2006, 27: 436-441. PMID: 16671022, DOI: 10.1086/503690.
• Are Commonly Ordered Lab Tests Useful Screens for Alcohol Disorders in Older Male Veterans Receiving Primary Care?Reid MC, Guo Z, Van Ness PH, O'Connor PG, Concato J. Are Commonly Ordered Lab Tests Useful Screens for Alcohol Disorders in Older Male Veterans Receiving Primary Care? Substance Abuse 2006, 26: 25-32. PMID: 16687367, DOI: 10.1300/j465v26n02_04.
• Quality of Care for Acute Myocardial Infarction in Elderly Patients with Alcohol‐Related DiagnosesFiellin DA, O'Connor PG, Wang Y, Radford MJ, Krumholz HM. Quality of Care for Acute Myocardial Infarction in Elderly Patients with Alcohol‐Related Diagnoses. Alcohol Clinical And Experimental Research 2006, 30: 70-75. PMID: 16433733, DOI: 10.1111/j.1530-0277.2006.00001.x.
• Buprenorphine tablet versus liquid: A clinical trial comparing plasma levels, efficacy, and symptomsChawarski MC, Moody DE, Pakes J, O'Connor PG, Schottenfeld RS. Buprenorphine tablet versus liquid: A clinical trial comparing plasma levels, efficacy, and symptoms. Journal Of Substance Use And Addiction Treatment 2005, 29: 307-312. PMID: 16311183, DOI: 10.1016/j.jsat.2005.08.011.
• Methods of Detoxification and Their Role in Treating Patients With Opioid DependenceO’Connor P. Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence. JAMA 2005, 294: 961-963. PMID: 16118388, DOI: 10.1001/jama.294.8.961.
• The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?Sullivan LE, Chawarski M, O’Connor P, Schottenfeld RS, Fiellin DA. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug And Alcohol Dependence 2005, 79: 113-116. PMID: 15943950, DOI: 10.1016/j.drugalcdep.2004.12.008.
• Primary Intensive Care: Pilot Study of a Primary CareBased Intervention for High-Utilizing PatientsBrown KE, Levine JM, Fiellin DA, O'connor P, Sledge WH. Primary Intensive Care: Pilot Study of a Primary CareBased Intervention for High-Utilizing Patients. Population Health Management 2005, 8: 169-177. PMID: 15966782, DOI: 10.1089/dis.2005.8.169.
• The prevalence and impact of alcohol problems in major depression: A systematic reviewSullivan LE, Fiellin DA, O’Connor P. The prevalence and impact of alcohol problems in major depression: A systematic review. The American Journal Of Medicine 2005, 118: 330-341. PMID: 15808128, DOI: 10.1016/j.amjmed.2005.01.007.
• Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency DepartmentD'Onofrio G, Pantalon M, Degutis L, Fiellin D, O'Connor P. Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department. Academic Emergency Medicine 2005, 12: 249-256. DOI: 10.1111/j.1553-2712.2005.tb00879.x.
• Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency DepartmentD'Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, O'Connor PG. Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department. Academic Emergency Medicine 2005, 12: 249-256. PMID: 15741590, PMCID: PMC1414059, DOI: 10.1197/j.aem.2004.10.021.
• Problem Drinkers: Find Them, Keep Them, Don't Lose Them—Treat ThemO'Connor PG. Problem Drinkers: Find Them, Keep Them, Don't Lose Them—Treat Them. Journal Of General Internal Medicine 2005, 20: 96-97. PMID: 15693936, PMCID: PMC1490046, DOI: 10.1111/j.1525-1497.2005.04005.x.
• Alcohol Abuse and Dependency.O’Connor PG. Alcohol Abuse and Dependency. In ACP Medicine Textbook. American College of Physicians, 2005, Vol. 2, pp. 2555-2563.
• 2004 update on addiction medicine/psychiatry in the state of Connecticut.Kraus ML, Kirk TA, Savage B, Patrich S, O’Connor PG, Babor TF, D’Onofrio G, Kosten TR, Kranzler H, Fiellin D, Schottenfeld RS. 2004 update on addiction medicine/psychiatry in the state of Connecticut. Connecticut Medicine 2005, 69(4): 217-225.
• Assessing the Teaching Behaviors of Ambulatory Care PreceptorsKernan WN, Holmboe E, O'Connor PG. Assessing the Teaching Behaviors of Ambulatory Care Preceptors. Academic Medicine 2004, 79: 1088-1094. PMID: 15504778, DOI: 10.1097/00001888-200411000-00017.
• Counseling Requirements for Buprenorphine Maintenance in Primary CarePantalon M, Fiellin D, O’Connor P, Chawarski M, Pakes J, Schottenfeld R. Counseling Requirements for Buprenorphine Maintenance in Primary Care. Addictive Disorders & Their Treatment 2004, 3: 71-76. DOI: 10.1097/00132576-200406000-00003.
• Processes of Care During a Randomized Trial of Office‐based Treatment of Opioid Dependence in Primary CareFiellin DA, O'Connor PG, Chawarski M, Schottenfeld RS. Processes of Care During a Randomized Trial of Office‐based Treatment of Opioid Dependence in Primary Care. American Journal On Addictions 2004, 13: s67-s78. PMID: 15204676, DOI: 10.1080/10550490490440843.
• Medical disorders in substance abuse patients.Sullivan LE, O’Connor PG. Medical disorders in substance abuse patients. In Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders, 2nd edition, eds. Kranzler HR, Tinsley JA, Marcel Dekker Inc., New York, NY, 2004, pp. 515-553.
• Counseling requirements for buprenorphine maintenance in primary care: lessons learned from a preliminary study in a methadone maintenance program.Pantalon MV, Fiellin DA, O’Connor PG, Chawarski MC, Pakes JR, Schottenfeld RS. Counseling requirements for buprenorphine maintenance in primary care: lessons learned from a preliminary study in a methadone maintenance program. Addictive Disorders and Their Treatment 2004, 3(2):71-76.
• Alcohol Abuse and Dependence.O’Connor PG. Alcohol Abuse and Dependence. In Cecil Textbook of Medicine, 22nd Edition, W.B. Saunders Company, A Division of Harcourt Health Science, 2004.
• Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care: A Nested Sequence of 3 Randomized TrialsO'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG. Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care: A Nested Sequence of 3 Randomized Trials. JAMA Internal Medicine 2003, 163: 1695-1704. PMID: 12885685, DOI: 10.1001/archinte.163.14.1695.
• Measuring Alcohol Consumption Among Older Adults: A Comparison of Available MethodsReid MC, Tinetti ME, O'Connor PG, Kosten TR, Concato J. Measuring Alcohol Consumption Among Older Adults: A Comparison of Available Methods. American Journal On Addictions 2003, 12: 211-219. PMID: 12851017, DOI: 10.1111/j.1521-0391.2003.tb00649.x.
• Management of Drug and Alcohol WithdrawalKosten TR, O'Connor PG. Management of Drug and Alcohol Withdrawal. New England Journal Of Medicine 2003, 348: 1786-1795. PMID: 12724485, DOI: 10.1056/nejmra020617.
• Measuring Alcohol Consumption Among Older Adults: A Comparison of Available MethodsCarrington Reid M, Tinetti M, O'Connor P, Kosten T, Concato J. Measuring Alcohol Consumption Among Older Adults: A Comparison of Available Methods. American Journal On Addictions 2003, 12: 211-219. DOI: 10.1080/10550490390203388.
• Connecticut statewide addiction medicine/psychiatry grand rounds.Kraus ML, O'Connor P, Babor TF, Brunell RJ, Fiellin DA, Holmboe E, Kirk TA, Leone P. Connecticut statewide addiction medicine/psychiatry grand rounds. Connecticut Medicine 2003, 67: 357-9. PMID: 12956044.
• Alcohol Abuse. PIER Clinical Guidance from American College of Physicians.Fiellin DA and O’Connor PG. Alcohol Abuse. PIER Clinical Guidance from ACP. American College of Physicians, 2003, pp. 1-34.
• Primary Health Care Settings, Section IV, Treatment Settings.O’Connor PG and Fiellin DA. Primary Health Care Settings, Section IV, Treatment Settings. In Handbook of Clinical Alcoholism Treatment, 1st edition, Lippincott Williams & Wilkins, 2003.
• A Staging System to Predict Prognosis Among Methadone Maintenance Patients, Based on Admission CharacteristicsFavrat B, Rao S, O'Connor P, Schottenfeld R. A Staging System to Predict Prognosis Among Methadone Maintenance Patients, Based on Admission Characteristics. Substance Abuse 2002, 23: 233-244. DOI: 10.1023/a:1021150217215.
• A Staging System to Predict Prognosis among Methadone Maintenance Patients, Based on Admission CharacteristicsFavrat B, Rao S, O'Connor PG, Schottenfeld R. A Staging System to Predict Prognosis among Methadone Maintenance Patients, Based on Admission Characteristics. Substance Abuse 2002, 23: 233-244. PMID: 12438836, DOI: 10.1080/08897070209511496.
• New federal initiatives to enhance the medical treatment of opioid dependence.Fiellin DA, O'Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Annals Of Internal Medicine 2002, 137: 688-92. PMID: 12379070, DOI: 10.7326/0003-4819-137-8-200210150-00014.
• Office-Based Treatment of Opioid-Dependent PatientsFiellin DA, O'Connor PG. Office-Based Treatment of Opioid-Dependent Patients. New England Journal Of Medicine 2002, 347: 817-823. PMID: 12226153, DOI: 10.1056/nejmcp013579.
• The Health–Related Effects of Alcohol Use in Older Persons: A Systematic ReviewReid M, Boutros N, O'Connor P, Cadariu A, Concato J. The Health–Related Effects of Alcohol Use in Older Persons: A Systematic Review. Substance Abuse 2002, 23: 149-164. PMID: 12444348, DOI: 10.1080/08897070209511485.
• The Physician's Role in Caring for Patients with Substance use Disorders: Implications for Medical Education and TrainingFiellin DA, Butler R, D'Onofrio G, Brown RL, O'Connor PG. The Physician's Role in Caring for Patients with Substance use Disorders: Implications for Medical Education and Training. Substance Abuse 2002, 23: 207-222. PMID: 23580996, DOI: 10.1080/08897070209511516.
• The Health-Related Effects of Alcohol Use in Older Persons: A Systematic ReviewReid MC, Boutros NN, O'Connor PG, Cadariu A, Concato J. The Health-Related Effects of Alcohol Use in Older Persons: A Systematic Review. Substance Abuse 2002, 23: 149-164. DOI: 10.1023/a:1019896822588.
• Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility studyBroadhead RS, Heckathorn DD, Altice FL, van Hulst Y, Carbone M, Friedland GH, O’Connor P, Selwyn PA. Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Social Science & Medicine 2002, 55: 235-246. PMID: 12144138, DOI: 10.1016/s0277-9536(01)00167-8.
• Use of Alcohol, Illicit Drugs, and Tobacco Among Characters on Prime-Time TelevisionLong J, O'Connor P, Gerbner G, Concato J. Use of Alcohol, Illicit Drugs, and Tobacco Among Characters on Prime-Time Television. Substance Abuse 2002, 23: 95-103. DOI: 10.1023/a:1015387222256.
• Risk for Delirium Tremens in Patients with Alcohol Withdrawal SyndromeFiellin D, O'Connor P, Holmboe E, Horwitz R. Risk for Delirium Tremens in Patients with Alcohol Withdrawal Syndrome. Substance Abuse 2002, 23: 83-94. DOI: 10.1023/a:1015350005418.
• Risk for Delirium Tremens in Patients with Alcohol Withdrawal Syndrome1Fiellin DA, O'Connor PG, Holmboe ES, Horwitz RI. Risk for Delirium Tremens in Patients with Alcohol Withdrawal Syndrome1. Substance Abuse 2002, 23: 83-94. PMID: 12444353, DOI: 10.1080/08897070209511478.
• Use of Alcohol, Illicit Drugs, and Tobacco among Characters on Prime–Time TelevisionLong JA, O'Connor PG, Gerbner G, Concato J. Use of Alcohol, Illicit Drugs, and Tobacco among Characters on Prime–Time Television. Substance Abuse 2002, 23: 95-103. PMID: 12444354, DOI: 10.1080/08897070209511479.
• Substance AbuseO'Connor PG, Samet JH. Substance Abuse. Journal Of General Internal Medicine 2002, 17: 398-399. PMID: 12047739, PMCID: PMC1495043, DOI: 10.1046/j.1525-1497.2002.20212.x.
• Substance abuseO’Connor P, Samet J. Substance abuse. Journal Of General Internal Medicine 2002, 17: 398-399. DOI: 10.1007/s11606-002-0047-0.
• Use of Opioid Medications for Chronic Noncancer Pain Syndromes in Primary CareReid MC, Engles‐Horton L, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of Opioid Medications for Chronic Noncancer Pain Syndromes in Primary Care. Journal Of General Internal Medicine 2002, 17: 173-179. PMID: 11929502, PMCID: PMC1495018, DOI: 10.1046/j.1525-1497.2002.10435.x.
• Treatment of heroin dependence with buprenorphine in primary careFiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Treatment of heroin dependence with buprenorphine in primary care. The American Journal Of Drug And Alcohol Abuse 2002, 28: 231-241. PMID: 12014814, DOI: 10.1081/ada-120002972.
• Patients with Alcohol ProblemsFiellin D, Reid M, O'Connor P. Patients with Alcohol Problems. Annals Of Internal Medicine 2001, 135: 841. DOI: 10.7326/0003-4819-135-9-200111060-00020.
• Methadone Maintenance in Primary Care: A Randomized Controlled TrialFiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone Maintenance in Primary Care: A Randomized Controlled Trial. JAMA 2001, 286: 1724-1731. PMID: 11594897, DOI: 10.1001/jama.286.14.1724.
• Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other InvolvementCarroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ. Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement. JAMA Psychiatry 2001, 58: 755-761. PMID: 11483141, PMCID: PMC3651594, DOI: 10.1001/archpsyc.58.8.755.
• Treatment of Heroin DependenceO'Connor P, Fiellin D. Treatment of Heroin Dependence. Annals Of Internal Medicine 2001, 134: 714. DOI: 10.7326/0003-4819-134-8-200104170-00017.
• A call for papersO’Connor P, Samet J. A call for papers. Journal Of General Internal Medicine 2001, 16: 70-71. DOI: 10.1046/j.1525-1497.2001.01107.x.
• A Call for PapersO'Connor P, Samet J. A Call for Papers. Journal Of General Internal Medicine 2001, 16: 70-71. PMID: 11251754, PMCID: PMC1495159, DOI: 10.1111/j.1525-1497.2001.01107.x.
• Prescription opioid abuse and potential role of office-based opioid maintenance treatment in integrating medical and substance abuse care.O’Connor PG. Prescription opioid abuse and potential role of office-based opioid maintenance treatment in integrating medical and substance abuse care. Topics in HIV Medicine. 2001, 9(5)10-14.
• Treating opioid dependence (Letter).O’Connor PG. Treating opioid dependence (Letter). The New England Journal of Medicine 2001, 344.
• AIDS oncology.O'Connor PG, Scadden DT. AIDS oncology. Infectious Disease Clinics Of North America 2000, 14: 945-65, vii. PMID: 11144646, DOI: 10.1016/s0891-5520(05)70141-0.
• Outpatient management of patients with alcohol problems.Fiellin DA, Reid MC, O'Connor PG. Outpatient management of patients with alcohol problems. Annals Of Internal Medicine 2000, 133: 815-27. PMID: 11085845, DOI: 10.7326/0003-4819-133-10-200011210-00015.
• Treating opioid dependence--new data and new opportunities.O'Connor PG. Treating opioid dependence--new data and new opportunities. The New England Journal Of Medicine 2000, 343: 1332-4. PMID: 11058680, DOI: 10.1056/NEJM200011023431809.
• Screening for Alcohol Problems in Primary Care: A Systematic ReviewFiellin DA, Reid MC, O'Connor PG. Screening for Alcohol Problems in Primary Care: A Systematic Review. JAMA Internal Medicine 2000, 160: 1977-1989. PMID: 10888972, DOI: 10.1001/archinte.160.13.1977.
• Pharmacologic treatment of heroin-dependent patients.O'Connor P, Fiellin D. Pharmacologic treatment of heroin-dependent patients. Annals Of Internal Medicine 2000, 133: 40-54. PMID: 10877739, DOI: 10.7326/0003-4819-133-1-200007040-00008.
• Thrice-weekly versus daily buprenorphine maintenanceSchottenfeld R, Pakes J, O’Connor P, Chawarski M, Oliveto A, Kosten T. Thrice-weekly versus daily buprenorphine maintenance. Biological Psychiatry 2000, 47: 1072-1079. PMID: 10862807, DOI: 10.1016/s0006-3223(99)00270-x.
• Effective teaching for preceptors of ambulatory care: a survey of medical studentsKernan W, Lee M, Stone S, Freudigman K, O’Connor P. Effective teaching for preceptors of ambulatory care: a survey of medical students. The American Journal Of Medicine 2000, 108: 499-502. PMID: 10781784, DOI: 10.1016/s0002-9343(00)00301-6.
• Naltrexone-Induced Nausea in Patients Treated for Alcohol Dependence: Clinical Predictors and Evidence for Opioid-Mediated EffectsO'Malley S, Krishnan-Sarin S, Farren C, O'Connor P. Naltrexone-Induced Nausea in Patients Treated for Alcohol Dependence: Clinical Predictors and Evidence for Opioid-Mediated Effects. Journal Of Clinical Psychopharmacology 2000, 20: 69-76. PMID: 10653211, DOI: 10.1097/00004714-200002000-00012.
• New therapies for alcohol problems: application to primary careFiellin D, Reid M, O’Connor P. New therapies for alcohol problems: application to primary care. The American Journal Of Medicine 2000, 108: 227-237. PMID: 10723977, DOI: 10.1016/s0002-9343(99)00448-9.
• HIV post-exposure therapy for drug users in treatmentO'Connor P. HIV post-exposure therapy for drug users in treatment. Journal Of Substance Use And Addiction Treatment 2000, 18: 17-21. PMID: 10636602, DOI: 10.1016/s0740-5472(99)00015-x.
• Methadone treatment for opioid dependence.O’Connor PG. Methadone treatment for opioid dependence. Journal of Substance Abuse Treatment. 2000, 12(6): 423-428.
• Methadone Medical Maintenance: A training and Resource Guide for Office-based PhysiciansFiellin DA, Storti SA, Schottenfeld RS, Biscoe JD, Pantalon MV, O’Connor PG. Methadone Medical Maintenance: A training and Resource Guide for Office-based Physicians, Addiction Technology Transfer Center of New England, Providence, 2000.
• Primary care setting.78. O’Connor PG. Primary care setting. In Handbook of Alcoholism, eds. Zernig G, Saria A, Kurz M, O’Malley SS, CRC Press, New York, NY, 2000, pp. 165-72.
• Hypersensitivity pneumonitis induced by intranasal heroin useKarne S, D’Ambrosio C, Einarsson O, O’Connor P. Hypersensitivity pneumonitis induced by intranasal heroin use. The American Journal Of Medicine 1999, 107: 387-390. PMID: 10527043, DOI: 10.1016/s0002-9343(99)00244-2.
• Hazardous and Harmful Alcohol Consumption in Primary CareReid MC, Fiellin DA, O'Connor PG. Hazardous and Harmful Alcohol Consumption in Primary Care. JAMA Internal Medicine 1999, 159: 1681-1689. PMID: 10448769, DOI: 10.1001/archinte.159.15.1681.
• Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.Namkoong K, Farren CK, O'Connor PG, O'Malley SS. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. The Journal Of Clinical Psychiatry 1999, 60: 449-53. PMID: 10453799, DOI: 10.4088/jcp.v60n0706.
• Tuberculosis chemoprophylaxis using a liquid isoniazid‐methadone admixture for drug users in methadone maintenanceO'Connor PG, Shi JM, Henry S, Durante AJ, Friedman L, Selwyn PA. Tuberculosis chemoprophylaxis using a liquid isoniazid‐methadone admixture for drug users in methadone maintenance. Addiction 1999, 94: 1071-1075. PMID: 10707445, DOI: 10.1046/j.1360-0443.1999.947107112.x.
• Plasma concentrations of buprenorphine 24 to 72 hours after dosingChawarski MC, Schottenfeld RS, O’Connor P, Pakes J. Plasma concentrations of buprenorphine 24 to 72 hours after dosing. Drug And Alcohol Dependence 1999, 55: 157-163. PMID: 10402160, DOI: 10.1016/s0376-8716(98)00192-6.
• Office-Based Methadone Maintenance Treatment of Opioid Dependence.Fiellin DA, O’Connor PG, eds. Office-Based Methadone Maintenance Treatment of Opioid Dependence. Instructors Guide. Yale University School of Medicine, 1999.
• Complications of Drug Use.O’Connor PG. Complications of Drug Use. Proceedings of the American Academy of Addiction Psychiatry’s 10th Annual Meeting and Symposium, 1999.
• Alcohol abusers in primary care: readiness to change behaviorSamet J, O’Connor P. Alcohol abusers in primary care: readiness to change behavior. The American Journal Of Medicine 1998, 105: 302-306. PMID: 9809691, DOI: 10.1016/s0002-9343(98)00258-7.
• Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatmentDurante AJ, Selwyn PA, O'Connor PG. Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment. Addiction 1998, 93: 1393-1401. PMID: 9926545, DOI: 10.1046/j.1360-0443.1998.939139310.x.
• Reducing Bias in Observational Research on Alcohol Withdrawal SyndromeFiellin D, Samet J, O'Connor P. Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome. Substance Abuse 1998, 19: 23-31. PMID: 12511804, DOI: 10.1080/08897079809511370.
• Reducing Bias in Observational Research on Alcohol Withdrawal SyndromeFiellin DA, Samet JH, O'Connor PG. Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome. Substance Abuse 1998, 19: 23-31. DOI: 10.1023/a:1021352607169.
• Patients with Alcohol ProblemsO'Connor P, Schottenfeld R. Patients with Alcohol Problems. New England Journal Of Medicine 1998, 338: 592-602. PMID: 9475768, DOI: 10.1056/nejm199802263380907.
• Rapid and Ultrarapid Opioid Detoxification TechniquesO'Connor PG, Kosten TR. Rapid and Ultrarapid Opioid Detoxification Techniques. JAMA 1998, 279: 229-234. PMID: 9438745, DOI: 10.1001/jama.279.3.229.
• A call for scholarly review articles in Substance Abuse.O’Connor PG. A call for scholarly review articles in Substance Abuse. Substance Abuse 1998, 19(2):47.
• Management of opioid intoxication and withdrawal.O’Connor PG, Kosten TR. Management of opioid intoxication and withdrawal. In Principles of Addiction Medicine, 2nd Edition., eds. Graham AW, Schultz TK, American Society of Addiction Medicine, Inc., Chevy Chase, MD, 1998, pp. 457-64.
• Linkages of substance abuse with primary care and mental health treatment.O’Connor PG, Ziedonis DM. Linkages of substance abuse with primary care and mental health treatment. In Principles of Addiction Medicine, 2nd Edition, eds. Graham AW, Schultz TK, American Society of Addiction Medicine, Inc., Chevy Chase, MD, 1998, pp. 353-62.
• Patient assessment.Gourevitch MN, Selwyn PA, O’Connor PG. Patient assessment. In Management of Drug Users in the Community A Practical Handbook, ed. Robertson R, Arnold, London, 1998, pp. 193-213.
• Medical disorders in substance abuse patients.O’Connor PG. Medical disorders in substance abuse patients. In Dual Diagnosis Substance Abuse and Comorbid Medical and Psychiatric Disorders, eds. Kranzler HR, Rounsaville BJ, Marcel Dekker Inc., New York, NY, 1998, pp. 535-66.
• A Preliminary Investigation of the Management of Alcohol Dependence With Naltrexone by Primary Care ProvidersO’Connor P, Farren C, Rounsaville B, O’Malley S. A Preliminary Investigation of the Management of Alcohol Dependence With Naltrexone by Primary Care Providers. The American Journal Of Medicine 1997, 103: 477-482. PMID: 9428830, DOI: 10.1016/s0002-9343(97)00271-4.
• Three methods of opioid detoxification in a primary care setting. A randomized trial.O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting. A randomized trial. Annals Of Internal Medicine 1997, 127: 526-30. PMID: 9313020, DOI: 10.7326/0003-4819-127-7-199710010-00004.
• PREFACESAMET J, STEIN M, O`CONNOR P. PREFACE. Medical Clinics Of North America 1997, 81: xiii-xiv. DOI: 10.1016/s0025-7125(05)70550-2.
• PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSEWarner E, Kosten T, O'Connor P. PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE. Medical Clinics Of North America 1997, 81: 909-925. PMID: 9222260, DOI: 10.1016/s0025-7125(05)70555-1.
• PHYSICIAN IMPAIRMENT BY SUBSTANCE ABUSEO'Connor P, Spickard A. PHYSICIAN IMPAIRMENT BY SUBSTANCE ABUSE. Medical Clinics Of North America 1997, 81: 1037-1052. PMID: 9222267, DOI: 10.1016/s0025-7125(05)70562-9.
• The Impact of the Yale Faculty Development Program: Clinical Alcohol and Drug Research and Education (CADRE) on Medical Student Teaching about Substance Abuse1O'Connor P, Pearsall H, Ball S, Forsyth B, Faraclas W, Schottenfeld R. The Impact of the Yale Faculty Development Program: Clinical Alcohol and Drug Research and Education (CADRE) on Medical Student Teaching about Substance Abuse1. Substance Abuse 1997, 18: 33-40. DOI: 10.1080/08897079709511344.
• Sustained-release methylphenidate for cognitive impairment in HIV-1- infected drug abusers: a pilot studyvan Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR. Sustained-release methylphenidate for cognitive impairment in HIV-1- infected drug abusers: a pilot study. Journal Of Neuropsychiatry 1997, 9: 29-36. PMID: 9017526, DOI: 10.1176/jnp.9.1.29.
• Site accommodations and preceptor behaviors valued by 3rd‐year students in ambulatory internal medicine clerkshipsKernan W, O'Connor P. Site accommodations and preceptor behaviors valued by 3rd‐year students in ambulatory internal medicine clerkships. Teaching And Learning In Medicine 1997, 9: 96-102. DOI: 10.1080/10401339709539822.
• Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide TKosten T, Rosen M, McMahon T, Bridge T, O'malley S, Pearsall R, O'connor P. Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T. The American Journal Of Drug And Alcohol Abuse 1997, 23: 543-553. PMID: 9366972, DOI: 10.3109/00952999709016894.
• Effective medical treatment of heroin addiction.O’Connor PG. Effective medical treatment of heroin addiction. Abstracts of Clinical Care Guidelines, 1997.
• Substance Abuse and Internal Medicine.Samet JH, Stein MD, O’Connor PG. Substance Abuse and Internal Medicine. In Medical Clinics of North America: Alcohol and Other Substance Abuse, eds. Samet JH, Stein MD, O’Connor PG, W.B. Saunders Company. Philadelphia, 1997, 81(4), pp. xiii-xiv.
• Medical issues in the care of opioid dependent patients.O’Connor PG, Selwyn PA. Medical issues in the care of opioid dependent patients. In New Treatments for Opioid Dependence, eds. Stine SM, Kosten TR, Guilford Publications, Inc. New York, NY, 1997, pp. 199-227.
• Site accommodations and preceptor behavior valued by 3rd-year students in ambulatory internal medicine clerkships.Kernan WN, O’Connor PG. Site accommodations and preceptor behavior valued by 3rd-year students in ambulatory internal medicine clerkships. Teaching and Learning in Medicine 1997, 9(2):96-102.
• The impact of the Yale faculty development program: Clinical alcohol and drug research and education (CADRE) on medical student teaching about substance abuse.O’Connor PG, Pearsall HR, Ball SA, Forsyth BWC, Faraclas WG, Schottenfeld RS. The impact of the Yale faculty development program: Clinical alcohol and drug research and education (CADRE) on medical student teaching about substance abuse. Substance Abuse 1997, 18(1):33-40.
• Drug Impaired Professionals.O’Connor PG. Drug Impaired Professionals. The New England Journal of Medicine 1997, 337(15):1093-4.
• The substance-using human immunodeficiency virus patient: Approaches to outpatient managementO'Connor P, Samet J. The substance-using human immunodeficiency virus patient: Approaches to outpatient management. The American Journal Of Medicine 1996, 101: 435-444. PMID: 8873515, DOI: 10.1016/s0002-9343(96)00200-8.
• Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1O'Connor P, Williams A. Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1. Substance Abuse 1996, 17: 101-109. DOI: 10.1080/08897079609444734.
• A Pilot Study of Primary-Care—Based Buprenorphine Maintenance for Heroin DependenceO'Connor P, Oliveto A, Shi J, Triffleman E, Carroll K, Kosten T, Rounsaville B. A Pilot Study of Primary-Care—Based Buprenorphine Maintenance for Heroin Dependence. The American Journal Of Drug And Alcohol Abuse 1996, 22: 523-531. PMID: 8911590, DOI: 10.3109/00952999609001678.
• Identification and treatment of substance abuse in primary care settings. The general internist.O’Connor PG. Identification and treatment of substance abuse in primary care settings. The general internist. The American Journal on Addictions 1996, 5(4) Suppl 1:S9-S19.
• Substance abuse and HIV/AIDS in Poland: Opportunities for educational exchange.O’Connor PG, Williams AB. Substance abuse and HIV/AIDS in Poland: Opportunities for educational exchange. Substance Abuse 1996, 17(2):101-9.
• Glycosylated hemoglobin: A new look at an old friend.O’Connor PG. Glycosylated hemoglobin: A new look at an old friend. Cortlandt Forum 1996, 9(12):73.
• HCFA Guidelines for teaching: The new world order.O’Connor PG. HCFA Guidelines for teaching: The new world order. Cortlandt Forum 1996, 9(10):72.
• Medical and nutritional complications of alcoholism: Mechanisms and management.O’Connor PG. Medical and nutritional complications of alcoholism: Mechanisms and management. Substance Abuse, Plenum Publishing Corporations, New York, NY, 1996, 17(3):175.
• Engaging the patient in treatment.O’Connor PG. Engaging the patient in treatment. In Clinical Manual of Substance Abuse, 2nd edition, ed. Kinney J, Mosby-Year Book, Inc., 1996, pp. 57-73.
• Routine screening and initial assessment.O’Connor PG. Routine screening and initial assessment. In Clinical Manual of Substance Abuse, 2nd edition ed. Kinney J, Mosby-Year Book, Inc., 1996, pp. 40-56.
• Models of Medical Care for HIV-infected Drug UsersSamet J, Stein M, O'Connor P. Models of Medical Care for HIV-infected Drug Users. Substance Abuse 1995, 16: 131-139. DOI: 10.1080/08897079509444716.
• Primary care-based ambulatory opioid detoxificationO’Connor P, Waugh M, Carroll K, Rounsaville B, Diagkogiannis I, Schottenfeld R. Primary care-based ambulatory opioid detoxification. Journal Of General Internal Medicine 1995, 10: 255-260. PMID: 7616334, DOI: 10.1007/bf02599882.
• Challenges in caring for injection drug users with HIV infection: Lessons from the United States for Poland.O’Connor PG. Challenges in caring for injection drug users with HIV infection: Lessons from the United States for Poland. In HIV/AIDS: Social and Medical Aspects. The University of Gdansk Press, Gdansk, Poland, 1995, pp. 211-19.
• Female drug users with HIV infection: Issues for medical care and substance abuse treatment.Selwyn PA, O’Connor PG, Schottenfeld RS. Female drug users with HIV infection: Issues for medical care and substance abuse treatment. In HIV Infection in Women, eds. Minkoff H, DeHovitz JA, Duerr A, Raven Press, 1995, pp. 241-62.
• Models of medical care for HIV-infected drug users.Samet JH, Stein MD, O’Connor PG. Models of medical care for HIV-infected drug users. Substance Abuse 1995, 16(3):131-9.
• HIV vaccine preparedness trials in injection-drug users: Are we prepared?O’Connor PG, Meandzija B, Poling J, Kosten T, Fitzgerald B, Rounsaville B. HIV vaccine preparedness trials in injection-drug users: Are we prepared? Substance Abuse 1995, 16:195-203
• Guidelines for the use of naltrexone in the treatment of alcoholism.Rounsaville BJ, O’Malley S, O’Connor PG. Guidelines for the use of naltrexone in the treatment of alcoholism. The APT Foundation, New Haven, CT, 1995.
• Substance abuse issues.Williams AB, O’Connor PG. Substance abuse issues. In Primary Care of Women and Children with HIV Infection, eds. Kelly P, Holman S, Rothenberg R, Holzemer SP, Jones and Barlett, Inc., 1995, pp. 217-38.
• SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphinevan Dyck C, Rosen M, Thomas H, McMahon T, Wallace E, O'Connor P, Sullivan M, Krystal J, Hoffer P, Woods S, Kosten T. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Research 1994, 55: 181-191. PMID: 7701033, DOI: 10.1016/0925-4927(94)90013-2.
• HIV infection and cocaine use in methadone maintained and untreated intravenous drug usersMeandzija B, O'Connor P, Fitzgerald B, Rounsaville B, Kosten T. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug And Alcohol Dependence 1994, 36: 109-113. PMID: 7851277, DOI: 10.1016/0376-8716(94)90092-2.
• "Medicine on wheels": an opportunity for outreach and housestaff education.Barry M, Fleck E, Lentz S, Bell C, O'Connor P, Horwitz R. "Medicine on wheels": an opportunity for outreach and housestaff education. Connecticut Medicine 1994, 58: 535-9. PMID: 7956199.
• Medical Care for Injection-Drug Users with Human Immunodeficiency Virus InfectionO'Connor P, Selwyn P, Schottenfeld R. Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection. New England Journal Of Medicine 1994, 331: 450-459. PMID: 8035842, DOI: 10.1056/nejm199408183310707.
• Management of hospitalized intravenous drug users: Role of the internistO'Connor P, Samet J, Stein M. Management of hospitalized intravenous drug users: Role of the internist. The American Journal Of Medicine 1994, 96: 551-558. PMID: 8017454, DOI: 10.1016/0002-9343(94)90096-5.
• Methadone maintenance programs should be developed in Poland.O’Connor PG. Methadone maintenance programs should be developed in Poland. Proceedings of Other IVDU Rehabilitative Programs in the Prevention of HIV/AIDS. Warsaw, Poland, September 12-14, 1994, pp. 213-15.
• Comprehensive care of injection drug users: The role of methadone maintenance and primary medical care.O’Connor PG. Comprehensive care of injection drug users: The role of methadone maintenance and primary medical care. Proceedings of Other IVDU Rehabilitative Programs in the Prevention of HIV/AIDS. Warsaw, Poland, September 12-14, 1994, pp. 107-19.
• Opioid intoxication and withdrawal.O’Connor PG, Kosten TR. Opioid intoxication and withdrawal. In Principles of Addiction Medicine, ed. Miller N, American Society of Addiction Medicine. Chevy Chase, MD, 1994, pp.1-6.
• The General Internist.O'Connor PG. The General Internist. Alcohol Research 1994, 18: 110-116. PMID: 31798132, PMCID: PMC6876412.
• Legality of methadone treatmentPeyser N, O’Connor P. Legality of methadone treatment. Journal Of General Internal Medicine 1993, 8: 286-286. PMID: 8389402, DOI: 10.1007/bf02600102.
• Substance abuse and AIDS: a faculty development program for primary care providers.O'Connor PG, Bigby J, Gallagher D. Substance abuse and AIDS: a faculty development program for primary care providers. Journal Of General Internal Medicine 1993, 8: 266-8. PMID: 8505687, DOI: 10.1007/BF02600095.
• The linkage of primary care services with substance abuse treatmentStein M, Samet J, O’Connor P. The linkage of primary care services with substance abuse treatment. Journal Of General Internal Medicine 1993, 8: 106-107. PMID: 8382743, DOI: 10.1007/bf02599995.
• The impact of gender on clinical characteristics and outcome in alcohol withdrawalO'Connor P, Horwitz R, Gottlieb L, Kraus M, Segal S. The impact of gender on clinical characteristics and outcome in alcohol withdrawal. Journal Of Substance Use And Addiction Treatment 1993, 10: 59-61. PMID: 8450575, DOI: 10.1016/0740-5472(93)90099-n.
• Decline in intravenous drug use among treatment-seeking opiate usersSchottenfeld R, O'Malley S, Abdul-Salaam K, O'Connor P. Decline in intravenous drug use among treatment-seeking opiate users. Journal Of Substance Use And Addiction Treatment 1993, 10: 5-10. PMID: 8450573, DOI: 10.1016/0740-5472(93)90092-g.
• Challenges in caring for injection-drug users with HIV infection: Lessons from the United States for Poland.O’Connor PG. Challenges in caring for injection-drug users with HIV infection: Lessons from the United States for Poland. Proceedings from the Conference on HIV/AIDS. Gdansk, Poland, March 23-25, 1993.
• Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug UsersRosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett‐Smith H, Thomas H, Van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users. American Journal On Addictions 1992, 1: 332-338. DOI: 10.1111/j.1521-0391.1992.tb00359.x.
• Human immunodeficiency virus infection in intravenous drug users: A model for primary careO'Connor P, Molde S, Henry S, Shockcor W, Schottenfeld R. Human immunodeficiency virus infection in intravenous drug users: A model for primary care. The American Journal Of Medicine 1992, 93: 382-386. PMID: 1415300, DOI: 10.1016/0002-9343(92)90166-9.
• Ambulatory opiate detoxification and primary careO’Connor P, Waugh M, Schottenfeld R, Diakogiannis I, Rounsaville B. Ambulatory opiate detoxification and primary care. Journal Of General Internal Medicine 1992, 7: 532-534. PMID: 1403211, DOI: 10.1007/bf02599459.
• DIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTIONSelwyn P, O'Connor P. DIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTION. Primary Care Clinics In Office Practice 1992, 19: 119-156. PMID: 1594693, DOI: 10.1016/s0095-4543(21)00124-x.
• Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug UsersRosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett-Smith H, Thomas H, van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users. American Journal On Addictions 1992, 1: 332-338. DOI: 10.3109/10550499208993153.
• Primary care management of intravenous drug users.O’Connor PG, Samet JH. Primary care management of intravenous drug users. In Substance Abuse Education in General Internal Medicine: A Manual for Faculty, eds. Bigby J, Adger H, Bureau of Health Professions (HRSA) and Office of Treatment Improvement (ADAMHA), 1992.
• Medical complications of cocaine use.O’Connor PG, Chang G, Shi J. Medical complications of cocaine use. In Clinician’s Guide to Cocaine Addiction: Theory, Research and Treatment, eds. Kosten TR, Kleber HD, Guilford Press, New York, NY, 1992, pp. 241-72.
• Peptide T treatment of cognitive impairment in HIV and intravenous drug users.Rosen MI, Bridge TP, O’Malley SS, Pearsall HR, Martini B, O’Connor PG, Brett-Smith H, Thomas H, van Dyck C, Woods SW, Kosten TR. Peptide T treatment of cognitive impairment in HIV and intravenous drug users. The American Journal of the Addictions 1992, 1:1-7.
• Social and clinical features as predictors of outcome in outpatient alcohol withdrawalO’Connor P, Gottlieb L, Kraus M, Segal S, Horwitz R. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. Journal Of General Internal Medicine 1991, 6: 312-316. PMID: 1890501, DOI: 10.1007/bf02597427.
• Primary medical care for IVDU's: a model for future care.Schottenfeld RS, O'Connor PG. Primary medical care for IVDU's: a model for future care. NIDA Research Monograph 1989, 95: 403-4. PMID: 2641009.
• Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification.Weintraub M, Ginsberg G, Stein EC, Sundaresan PR, Schuster B, O'Connor P, Byrne LM. Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification. Clinical Pharmacology And Therapeutics 1986, 39: 501-9. PMID: 3516509, DOI: 10.1038/clpt.1986.87.
• Disturbance in heart rhythm-arrhythmias.O’Connor PG, Johnson GT. Disturbance in heart rhythm-arrhythmias. The Harvard Medical School Health Letter, 1982